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Abstract 
Deiodirtation of Thyroxine By Two 
NADP-Dependent Rat Liver Microsomal 
Deiodinase Activities 
By 
Benjamin D. L. Li 
1986 
The deiodination of thyroxine (3,3',5,5'-tetraiodothyronine, 
T^) by extrathyroidal tissues constitutes a critical pathway for the 
generation of the active metabolite, T^ (3,3’,5-triiodothyronine), as 
well as such species as reverse T^ (3,35’-triiodothyronine) and 
further degradative products of “the triiodothyronines. In our 
laboratory, solubilization of rat liver microsomes by a zwitterionic 
detergent, (3 —((3-cholamidopropyl)-dimethylammonio)-1-propane 
sulfonate (CHAPS), ^r^vealed dje^odinase activity detected by the 
generation of free I from I-T,. Further purification of the 
CHAPS-solubilized microsomal deiodinase activity by acidification and 
by DEAE-Sephadex A25 column chromatography resulted in the separation 
of the activity into two. The first peak of activity eluted as the 
"breakthrough" and "wash" fractions (deiodinase A) and was stimulated 
by the addition of NADP and DTT. The second peak of activity eluted 
with 0.4 M NaCl and ovalbumin (1.0 mg/ml) as the "eluate" fractions 
(deiodinase B) and was stimulated by NADP in the presence of 
phospholipids. Using a T^-specific radioimmunoassay, the generation 
of T^ was detected in deiodinase A which was enhanced by the addition 
of NADP and DTT. This finding supported the results of the T^ 
deiodinase assay. Much less T^ was detectable by radioimmunoassay in 
deiodinase B incubated with T^ with and without NADP and 
phospholipids. The generation of T^ by both deiod^i^ase activities A 
^{1 B was less than 1% of the amount of free I released from 
I-T,. This is consistent with the hypothesis that thyroxine is 
converted to T^ and rT^ and subsequently into further degradative 
products. The results presented here provide a basis for further 
studies on the purification of deiodinase activities by 
solubilization of microsomes with CHAPS. 
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Introduction 
The thyroid gland, derived from the Greek word, thyreos, 
meaning shield, is an endocrine organ whose secretion, the thyroid 
hormones, are involved in the regulation of cellular metabolism. 
The gland, as seen from the front, resembles more a butterfly than 
a shield. Developed as an evagination from the floor of the 
embryonic pharynx, the thyroid gland descends into the neck, 
finally resting with the upper margin of the isthmus at the level 
just below the cricoid cartilage. By the end of the third month of 
fetal development, colloid-containing follicles are visible and the 
release of thyroid hormones begins (16). 
The functional unit of the thyroid gland is the follicle. 
Microscopically, the follicle appears as a spheroidal structure 
with a single epithelial cell layer surrounding a 
colloid-containing lumen. The colloid is generally a homogenous 
solution, principally consisting of thyroglobulin, the 
iodoglycoprotein from which the thyroid hormones are derived. It is 
thus not surprising that the distribution of follicle size is in 
part a determinant of the kinetics of iodine turnover in the gland 
to stimulants (27,53). 
> 
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Synthesis of iodothyronines : 
The physiologically active thyroid hormones, thyroxine 
(3,3',5,5'-tetraiodothyronine, T^) , and 3,3’5-triiodothyronine 
(T^) , are synthesized in the follicle by iodination and 
condensation of the tyrosyl residue in thyroglobulin. (For 
structures of the iodothyronines, please refer to FIG. 1.) An 
inactive form of triiodothyronine, iodinated at the 3,3',5’ 
positions, named reverse (rT^) , is also synthesized in small 
amounts. 
Thyroglobulin, a 660,000 dalton iodoglycoprotein, is 
synthesized in the thyroid cell. It contains three percent tyrosine 
by weight. Seventy percent of these tyrosyl residues are 
susceptible to iodination as shown by spatial studies (30). In the 
thyroid cell, the backbone of the polypeptide is assembled on 
polyribosomes on the rough endoplasmic reticulum . It is then 
processed and glycosylated in the smooth endoplasmic reticulum and 
golgi apparatus. During the process of secretion into the colloid 
by exocytosis, the tyrosyl residues are iodinated, forming 
monoiodotyrosines (MIT) and diiodotyrosines (DIT). The iodination 
reaction is catalyzed by peroxidase (9). 
After a lag time of fourteen to sixty minutes, condensation 
of an iodinated hydroxypheny1 group of one peptide-linked 
iodotyrosine to the phenolic hydoxyl group of another peptide- 
linked iodotyrosine occurs (8). This results in the release of an 
. 
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alanine residue and the formation of thyroxine when DIT is coupled 
to DIT, and or rT^ when MIT is coupled with DIT (20) 
Hormone secretion and mode of action : 
The secretory process of thyroid hormones begins with the 
endocytosis of globules of the thyroglobulin-containing colloid. 
Once inside the cell, fusion with lysosomes occur w^ith subsequent 
proteolysis of the glycoprotein to component amino acids, the 
iodinated tyrosyl residues (MIT and DIT), and the iodothyronines. 
The iodothyronines are subsequently released into the bloodstream 
while the iodinated tyrosyl residues and amino acids in the thyroid 
cells are recycled. This process is regulated by thyroid 
stimulating hormone (TSH) in a cAMP-dependent manner (9). 
The fundamental action of the thyroid hormone appears to be 
exerted at the nuclear level. Receptors in the nuclei of target 
cells bind the thyroid hormones, especially Tn, with high affinity. 
The hormone-receptor complex activates the chromatin by an unknown 
mechanism, leading to the increased activities of polymerase I and 
II, and possibly chromatin template activity (5). This leads to 
enhanced synthesis of ribosomal and messenger RNA and consequently 
protein synthesis. This results in the influence of cellular 
functions. 
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Deiodination of thyroxine : 
Several pieces of evidence have suggested that is the 
active forin of thyroid hormone. Intracellular ly is the 
predominant thyroid hormone (9). T0 has been shown to bind ten to 
fifteen times as tightly to the thyroid hormone nuclear receptor as 
does (5). When deiodination of to was blocked, physiologic 
responses thought to be regulated by thyroid hormone were depressed 
or eliminated (9). 
The secreted T^/T^ ratio (approximately 10:1) is an 
indication of thyroidal T4/T^ ratio (9). Since is the active 
species, extrathyroidal deiodination of thyroxine constitutes a 
major pathway for thyroid hormone metabolism (for review articles, 
see 40,41,42). The development of sensitive and specific radio¬ 
immunoassays have greatly facilitated studies of deiodination 
pathways both in vivo and in vitro. The extrathyroidal conversion 
of thyroxine to triiodothyronine has been observed in homogenates 
of liver (22,40,41,42), kidney (15,22,26), thyroid (10), anterior 
pituitary (33), cerebral cortex and cerebellum (37,38). 
Initial studies by Visser et al. (42,43) of rat liver 
homogenates led to the hypothesis that enzymatic deiodination of 
thyroxine involves a two enzyme system : a 5'-deiodinase which 
converts T^ into 3,3’5-triiodothyronine (T^) and a 5-deiodinase 
which converts T^ into 3,3'5'-triiodothyronine (rT^). Reverse T^ is 
then rapidly degraded by the 5'-deiodinase to 3,3-diiodothvronine 
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O^’-T^). However, degradation to 3,3'-!^ by 5-deiodinase 
proceeds at a much slower rate (40,41,43) (See FIG. 2). 
Differential centrifugation of the liver homogenate revealed that 
majority of the deiodinating activities are recovered in the 
microsomal fraction (1,11,19,40,43). 
The conversion of thyroxine to triiodothyronine is a 
reductive process, replacing an iodinium atom by hydrogen. 
Microsomal preparations generally require the presence of 
thiol-group containing compounds (e.g. dithiothreitol (DTT)) 
for deiodination to proceed. The addition of thiouracil 
derivatives, such as propylthiouracil (PTU) and 2-thiouracil, in 
the presence of substrate, results in a progressive and 
irreversible decrease in the deiodination activity in the liver and 
kidneys (45,46), but not in the anterior pituitary and the central 
nervous system (6,24). Thus we can separate the deiodinase 
activities into PTU-sensitive and PTU-insensitive pathways. 
PTU-sensitive pathway : 
The PTU-sensitive pathway is responsible for greater than 
sixty percent of the extrathyroidal deiodination of T^ (9). 
Kinetic studies by Visser et al. (21,43,45) provided evidence for a 
ping-pong mechanism of deiodination (see FIG. 3). In the first half 
of the reaction, the enzyme interacts with T^, leading to T^ 
production and the transfer of an iodinium ion from the substrate 
"n.- 
6 
to a sulphydryl group on the enzyme. This results in the formation 
of an enzyme-sulphenyl-iodide complex (E-SI). A sulphvdryl- 
containing cofactor (DTT in vitro) then releases the enzyme from 
the E-SI complex thereby freeing the enzyme for the next round of 
reaction (45). Thiouracil analogs inhibit this reaction by 
reacting with the E-SI complex and forming a mixed disulfide bond. 
This creates a dead-end complex, thus terminating the reaction (45, 
46,52). 
Although the early results of Visser (42,44) and Hoffken 
(18), based on studies of pH optima and kinetics, predicted the 
existence of distinct 5’- and 5- deiodinases, recent data by Chopra 
(7) and Fekkes (13) suggested that the possibilty of a single 
enzyme responsible for both activities cannot be ruled out. That 
both the tyrosyl and the phenolic ring of iodothyronines are 
deiodinated by the same enzyme is supported by the following recent 
findings : 
A. Both activities have been localized to the microsomes and 
further fractionation has not separated their activities 
(1,11). 
B. Both reactions are reductive and require a thiol-containing- 
group compound such as DTT (41,43). 
C. Both activities are inhibited by thiouracil in an 
uncompetitive manner in the presence of a deiodinase- 
specific iodothyronine substrate (15,16,52). 
D. 3,5-diiodothyronine, a substrate which is specifically 
■ •*' 
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deiodinated by 5-deiodinase, can serve as the substrate 
requirement for 5'-deiodinase inhibition by thiouracil 
(46). 
E. 5- and 5'- deiodinase activities in polyoxyethylene ether 
W-l (W-l ether) extracts of rat liver microsomal fractions 
co-migrate on isoelectric focusing gels (18). 
F. The K values for the substrates undergoing 5-deiodination 
m 
are equal to their K. values for inhibition of 
5’-deiodination of the other substrates and vice versa (13). 
PTU-insensitive pathway : 
In the central nervous system and in the anterior pituitary, 
intracellular is derived predominantly by local conversion 
(25). Silva and Leonard et al. (34) showed in vitro the presence of 
a to 5’-deiodinating pathway in the cerebral cortex, the 
cerebellum, and the anterior pituitary, that was insensitive to PTU 
in the presence of DTT. In that same study, the liver deiodinase 
activity was inhibited seventy-six percent by PTU, suggesting that 
the PTU-insensitive pathway is quantitatively unimportant in the 
liver. 
Visser et al. (48) reported the existence of two 
5'-deiodinase activities in the cerebral cortex. One of these was 
specific for rT^, required DTT as a cofactor, was sensitive to PTU, 
and followed the ping-pong reaction model, as in the liver. This 
t *■ 
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deiodinase predominates in euthyroid and long-term hypothyroid 
rats. The other activity, found in short-term hypothyroid rats, 
preferred T. to rT„ as substrate, was insensitive to PTU, and 
4 3 
followed sequential reaction kinetics. The relative proportion of 
activity of these 5'-deioinase pathways was dependent on the 
thyroid status of the animal (47). 
Tanaka et al. (37) reported the presence in the C.N.S. of a 
5-monodeiodinase activity converting T^ to rT^ and T^ to 3,3'-^ 
that was dependent on DTT but not inhibited by PTU. This activity 
was localized to the synaptosomal fraction by ultracentrifugation 
method (10). In a later paper (38), using a 3,3’-T^-specific RIA, 
they showed that the 5’-deiodinase activity in rat brain which 
converts rT^ to 3,3’-T? was, however, sensitive to PTU. They 
suggested that the PTU-insensitive formation of 3,3'-T? reported by 
125 125 
Visser et al. (47), who measured release of I from I-rT^, was 
by a different pathway. Studying age related changes and different 
regional distribution of the enzymes, they concluded that rT^ 
5'-deiodinase and T^ or T^ 5-monodeiodinase are different enzymes 
(38). A definitive view of the deiodinase pathways in the C.N.S. 
has not been reached. 
Non-enzymatic pathways : 
The deiodination of thyroxine and related compounds by 
microsomes may also occur via non-enzymatic processes. Studies 
■ n 
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have shown certain deiodinaticn pathways to be accelerated with 
oxygen and metal ions (35,39). A NADP-dependent lipid peroxidation 
in a submicrosomal system (36) has also been reported. The 
physiological importance of these non-enzymatic pathways have not 
been established. 
Partial purification of two deiodinase activities : 
The deiodination of thyroxine by extrathvroidal tissues into 
T^, rT^, and further degardative products thus involves multiple 
pathways. A definitive view of the deiodination pathways has not 
been reached. The difficulty in arriving at a coherent picture for 
the extrathyrodial deiodination pathways rests in part on the 
failure to further purify the enzyme. The use of various detergents 
including cholate and deoxycholate to solubilize and purify 
deiodinase activities has been reported in the literature 
(14,26,29). This has only resulted in partial recovery of the 
deiodinase activity. 
In our laboratory, Watkins et al. found that solubilization 
of rat liver microsomes by the zwitterionic detergent, CHAPS, 
125 
revealed a deiodinase activity for which ^ I-labelled 
l-(p-hydroxyphenyl)-2-guanidinoethane was a substrate (52). It was 
125 
subsequently found that I-T^ was also deiodinated in this 
system. Preliminary results using labelled thyroxine revealed 
various breakdown products with HPLC (High Performance Liquid 
i'T9''9 
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Chromatography) peaks co-migrating with T^, rT^, , and free 
iodide (personal communication). This finding is consistent with 
the products of extrathyroidal deiodination of thyroxine reported 
in the literature. 
Using CHAPS detergent to solubilize microsomes represents an 
original purification procedure for deiodinase activity. Initial 
studies of the activity revealed a novel cofactor requirement; the 
deiodinase activity was stimulated up to ten fold by the presence 
of NADP, much less by NAD, and not at all by the reduced forms of 
these nucleotides, NADH and NADPH. The NADP effect was not observed 
with venom phosphodiesterase-treated NADP, suggesting that the 
enhancement was not due to a contaminant in the NADP preparation. 
Partial purification of the activity by DEAE-Sephadex A25 
column chromatography revealed two peaks of activity. Initial 
studies suggested that NADP with DTT and NADP in the presence of 
phospholipids may act as effectors. 
As CHAPS solubilization represented a novel purification 
procedure for the deiodinase activity, we proceeded to relate the 
detection of our two activities to those reported in the 
literature (1,2,7,10,11). Using a commercially available 
T^-specific radioimmunoassay kit, an assay system was designed to 
detect for T^ as a product of T^ metabolism in our preparation. In 
this study, we report the detection of a 5'-deiodinase activity in 
partially purified CHAPS-solubilized rat liver microsomes. On 
further purification, the deiodinase activity was recovered in the 
-i > 
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"breakthrough" and "wash" fractions from DEAE-Sephadex A25 column 
chromatography. This activity, deiodinase A, was stimulated by the 
addition of NADP and DTT. A second activity was recovered upon 
elution of the column with 0.4 M NaCl. This second activity, 
deiodinase B, is enhanced by the additon of NADP in the presence of 
phospholipids. The production of T^ as detected by the T^ radio- 
125 
immunoassay was less than one percent of the production of I 
125 
released by the I-T^ deiodinase assay. These findings are 
consistent with the hypothesis that thyroxine is converted to T^ 
and rT^ and subsequently into further degradative products as 
reported in the literature (37,38,40,41,42,43,47). The use of 
CHAPS to solubilize microsomal deiodinase activities may be used as 
a mean to further purify and characterize the identity of the 
various deiodinases present in extrathyroidal tissues. 
-rori - 
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Methods and Materials 
Materials and miscellaneous methods : 
Male Osborne-Mendel rats (6-8 weeks old) were obtained from the NIH 
breeding colony and were fed ad libitum; NAD, NADP, NADH, NADPH, and 
(diiodothyronine) were obtained from Sigma; (thyroxine), 
(3,5,3'-triiodothyronine), and rT^ (3,3'5'-triiodothyronine) were 
125 125 
obtained from Calbiochem; I-T^ an<^ I-T^ were obtained from New 
England Nuclear; 1^ radioimmunoassay kits were from Amersham; 
DTT (dithiothreitol), CHAPS (3-((3-cholamidopropyl)-dimethylammonio)- 
1-propane sulfonate), MES (2-(N-morpholino)ethanesulfonic acid), and 
Tris-HCl were obtained from Bethesda Research Laboratories; 
Phospholipids (Cat. # 6202) were obtained from Pharmacia L-P 
Biochemical; DEAE-Sephadex A25 was obtained from Pharmacia; Dowex AG 
50-X8 was obtained from Bio-Rad. Protein analysis was determined by 
the method of Lowry et al (28). 
Partial purification of the two deiodinase activities from the rat 
liver : 
A. Preparation of crude microsomes. 
Livers were homogenized (1:3, w/v) in 0.25 M sucrose containing 25 mM 
Tris-HCl, pH 7.4, with a Potter-Elvehjem homogenizer. Homogenates 
.... 
' 
13 
were centrifuged at 25 000 x g for 25 min. After removal of the 
floating fatty layer* the supernatant was further centrifuged for 60 
min. at 105 00 x g to sediment the microsomes. This microsomal pellet 
was then resuspended in 0.4 volumes of homogenization buffer (0.25 M 
sucrose in 25 mM Tris-HCl, pH 7.4). 
B. Detergent solubilization. 
Suspensions of microsomes were diluted 1:1 with homogenization buffer 
and CHAPS was added to a final CHAPS concentration of 0.8%. After 10 
min. on ice, the mixture was again centrifuged at 105 000 x g for 60 
min. 
C. Acid treatment. 
The pH of the CHAPS-soluble fraction (105 000 x g supernatant) was 
lowered by the addition of 0.1 volume of 1.0 M NaAcetate, pH 4.5. 
After 15 min. on ice, precipitated material was removed by 
centrifugation at 7 000 x g for 10 min. The supernatant was then 
removed and the pH adjusted to 7.0-7.5 by the addition of 1.0 M 
Tris-base. This will be referred to as the pH 4.5 supernatant. 
D. DEAE-Sephadex A25 chromatography. 
Small Column 
A column (0.8 x 5.0 cm) of DEAE-Sephadex A25 was equilibrated with 
25 mM Tris-HCl, pH 7.5, containing 0.8% CHAPS. The pH 4.5 supernatant 
was diluted 1:5 with this buffer. 2.0 ml was applied to the column. 
The sample was then washed in with 3.0 ml of buffer and collected as 
... 
14 
the "breakthrough". The column was further washed with three 5.0 ml 
portions of buffer. These are the "wash" fractions. Finally the 
column was eluted with successive 1.0 ml aliquots of buffer 
containing 0.4 M NaCl and ovalbumin (1.0 mg/ml) These are the 
"eluate" fractions. 
Large Column 
Volumes in the large column (2.5 x 3.0 cm) DEAE-Sephadex 25 were 
increased 1:5 volumes proportionally from the small column. 
E. Dialysis. 
To decrease the concentration of CHAPS, the enzyme preparations were 
dialyzed overnight against 7 volumes of 25 mM Tris-HCl, pH 7.5, at 4° 
C. 
Preparation of phospholipids : 
Phospholipids (Cat. # 6202), consisting of 12 uM phosphatidyl 
choline, 12 uM sphingomyelin, 12 uM phosphatidyl ethanolamine, 5.2 uM 
phosphatidyl serine, 0.4 uM cardiolipin, and 0.4 uM phosphatidyl 
inositol, were dissolved in 2.0 ml chloroform and stored at 20° C. 
Aliquots of 100 ul of phospholipids were prepared fresh for each 
assay by transferring the phospholipids to a glass tube, air dried 
with nitrogen gas at room temperature, and suspended in 600 ul of 50 
mM MES, pH 6.0, and ovalbumin (1.0 mg/ml). 

15 
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I-T^ deiodinase assay : 
Assays contained, in total volume of 0.1 ml, 50 mM MES, pH 6.0, 
ovalbumin (l.Omg/ml), 25 nM ^ ^I-T^ (approximately 100 000 
dpm/assay), 10 ul enzyme, and other additions as described for each 
experiment. After incubation for 10 min, at 30° C, the reaction was 
terminated by the addition of 1.0 ml of 10% acetic acid. Released 
125 
I was separated from the substrate by loading the entire sample on 
a 1.0 ml column of Dowex AG 50-X8 (equilibrated with 10% acetic acid) 
and washing the column with five 1.0 ml portions of 10% acetic acid. 
Radioactivity was then measured with a Beckman Auto-gamma counter. 
125 125 
Under these conditions, greater than 97% of I-T^ anc* I-T^ 
125 
remain bounded to the column whereas I was quantitatively eluted. 
radioimmunoassay: 
To determine the amount of formed during the deiodinase asssavs, 
incubation mixes were analyzed using a commercial radioimmunoassay 
kit obtained from Amersham. Incubations contained in a total volume 
of 0.25 ml, 50 mM MES, pH 6.0, ovalbumin (1.0 mg/ml), 1 uM T^, 0.2 ml 
enzyme, and other additions as described for each experiment. After 
20 min. at 30° C, the reaction was terminated by transferring a 0.2 
m.1 aliquot to a microfuge tube containing 0.4 ml ice-cold ethanol. 
' 
■ ■ 
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The tube was then spun for 15 min. and duplicate 50 ul aliquots of 
the supernatant were removed for radioimmunoassay. Samples were mixed 
125 
with 0.5 ml of I-T^ s°luti°n and 0*5 ml anti-T^ antibody solution. 
After incubation for 60 min, at 37° C, the tubes were centrifuged at 
1 500 x g for 15 min. at room temperature. Radioactivity in the 
pellet was then quantitated in a Beckman Auto-gammma counter. 
• ' -r . ' •' 
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Results 
Characterization of the radioimmunoassay : 
A commercially available T^-specific radioimmunoassay kit was 
used to detect 3,5,3'-triiodothyronine in our assay system. In Figure 
4, a semilog plot of a typical concentration curve is shown. This was 
generated under conditions typical of our unknown samples containing 
50 mM MES, pH 6.0, ovalbumin (1.0 mg/ml), 3 mM NADP, and 5 mM DTT. 
This curve is readily reproducible and is generated independently for 
each experiment. 
The specificity of a radioimmunoassay is critical to its 
usefulness. Therefore, we first checked the assay for 
cross-reactivity with other iodothyronines. Data supplied with 
the radioimmunassay kit stated that cross-reactivity of the anti-T^ 
antibody was, by weight, 0.8% for T0, less than 0.03% for rl^, and 
less than 0.3% for T^. In Table I, using standards obtained from 
Sigma and Calbiochem in our buffer system, cross-reactivities for T0, 
rT^, and T^ were 2.2%, 0.2% and 1.1% respectively. 
Detection of rat liver deiodinase activity by 125 I-T, 
Deiodinase activity in crude rat liver homogenates was detected 
- 
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as release of free I from "I-T. (FIG. 5, (H)). However, this 
4 
activity was not significantly increased when assays contained NADP. 
NADP-stimulated deiodinase activity was partially purified from 
homogenates as described in Methods. Previous results of differential 
centrifugation of rat liver homogenates showed that most of the 
NADP-stimulated deiodinase activity was in the microsomal fraction 
(data not shown). Activity of the microsomal fraction was found to be 
increased ten-fold when NADP was present (FIG. 5. (M)). 
Treatment of the microsomal preparation with 0.8% CHAPS 
effectively solubilized the deiodinase activity (FIG. 5, (C)). 
Acidification of the detergent-solubilized enzyme preparation 
with 0.1 vol NaAcetate, pH 4.5, caused the precipitaion of much of 
the microsomal protein. The deiodinase activity, however, remained in 
the supernatant. The pH 4.5 supernatant, which was subsequently 
neutralized to pH 7.0-7.5, exhibited higher total activity than 
either the microsomes or the CHAPS-solubilized fractions, suggesting 
that some inhibitory material had been removed (FIG. 5, (S)). 
To further purify the deiodinase activity of the pH 4.5 
supernatant, the preparation was subjected to chromatography on 
DEAE-Sephadex A25. As shown in Figure 6A, most of the NADP-dependent 
activity was present in the "breakthrough" (BT) and "wash" (W1,VJ2,W3) 
fractions. This activity, which we will refer to as deiodinase A, was 
stimulated by NADP or DTT. The presence of both effectors 
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synerglstically increased activity (FIG. 6B) . A second and much 
smaller activity peak eluted from the column with 0.4 M NaCl. This 
activity, deiodinase B, was not affected by DTT (FIG. 6B). 
Since many membrane associated enzymes require phospholipids 
(26), column fractions were assayed in the presence of phospholipids 
(for preparation, see Methods). As shown in Figure 7A and 7B, 
phospholipids increased the activity of deiodinase B. When NADP was 
present in addition to phospholipids, further enhancement of the 
activity in deiodinase B was observed (FIG. 7B) . The effect of NADP 
on deiodinase A activity was more significant than that of 
phospholipids. These results suggested that there are two deiodinase 
activities in the CHAPS-solubilized fraction of rat liver microsomes. 
Detection of rat liver deiodinase activity by T^ radioimmunoassay : 
Following the methodology described in the original report by 
Visser et al. (40) for the detection of T^ in rat liver homogenates 
by T^ radioimmunoassay, a modified T^ detection assay system was set 
up. 
Rat liver was homogenized in 3 volumes of 0.25 M sucrose in 25 mM 
Tris-HCl, pH 7.4, buffer, and centrifuged at 2,000 x g for 5 min. 
Using the supernatant, T^ was detected when thyroxine (final 
concentration = 1 uM) was added to the standard reaction mixture as 
described in Methods with and without the addition of 3 mM NADP and 
. ' r-f' 
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5 mM DTT (FIG. 8, (SUP 1)). The amount of detected was greater 
when NADP and DTT were present. 
The amount of T^ detected by the radioimmunoassay was in the 
picograms range. The final concentration of T^ introduced into the 
assay system was 1 uM. By cross-reactivity studies, 1.1% of T,_ may be 
detectable as T^ under our assay conditions. The addition of the same 
amount of T^ to our control assay (buffer without enzyme) thus serves 
as a baseline for cross-reactivity and the picograms of T^ detected 
above control corresponds to T^ generated. The values in the 
following graphs have been corrected for with subtractions of the 
controls and therefore reflect T^ generated. 
The homogenate supernatant was then subjected to the same 
partial purification process as for the enzyme preparation used in 
125 
the I-T^ deiodinase assay (see Methods). Deiodinase activity, as 
measured by T^ produced, was observed in the supernatant after 
centrifugation at 25,000 x g (FIG. 8. (SUP2)). The supernatant was 
then respun at 105,000 x g. Most of the deiodinase activity was 
recovered in the microsomes (FIG. 8. (SUP3) and (M)). The presence 
of NADP and DTT increased the conversion of thyroxine to T0. 
The addition of 0.8% CHAPS and centrifugation of enzyme 
preparation at 105,000 x g resulted in a CHAPS-soluble fraction and a 
CHAPS-pellet. Deiodinase activities were present in both (FIG. 9 
(C-SOL) and (C-PEL)). Acid treatment of the CHAPS-soluble fraction 
with NaAcetate resulted in a soluble fraction and precipitate. 
V -■ ■ 
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Neutralization and resuspension of respective preparations revealed 
less activity than the pretreatment CHAPS-soluble fraction (FIG. 9 
(4.5-SOL) and (4.5-PEL)). The majority of the activity remained in 
the soluble fraction. As shown, the deiodinase activity was 
detectable only with the addition of NADP, DTT and phospholipids. 
DEAE-Sephadex A25 column chromatography was used to partially 
purify the activity identified in the pH 4,5 supernatant. As shown in 
Table II, no deiodinase activity as measured by T^ radioimmunoassay 
was observed in deiodinase A. However T^ was detected when microsome 
and pH 4.5 supernatant were tested for deiodinase activity. The 
activity in microsomes was about 2 times that of the pH 4.5 
supernatant. 
125 
Using the same deiodinase A preparation as above, I-T^ was 
125 
used as substrate to test for deiodinase activity using the I-T^ 
deiodinase assay per Methods. Using this assay, 180 and 11.8 
125 
picograms of I-T^ were deiodinated by the enzyme preparation in 
the presence and absence of NADP and DTT respectively (data not 
shown). The results suggested that there may be inhibitory factor(s) 
] 25 
present in the T^ assay but not in the I-T^ deiodinase assay. 
A set of experiments were run to eliminate possible inhibitory 
125 
factor(s). Figure 10 shows the inhibition of the I-T. deiodinase 
4 
assay by increasing concentration of CHAPS. When the concentration of 
CHAPS exceeds 0.2%, complete inhibition of the deiodinase activity as 
125 
measured by the release of free I was observed. 
V < -I 
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The final concentration of CHAPS in the enzyme fractions from 
125 
chromatography were approximately 0.8%. In the I-T^ deiodinase 
assay, 10 ul of enzyme was used in a total reaction volume of 100 ul, 
resulting in a final concentration of 0.08% CHAPS. In the assay, 
200 ul of the 250 ul total volume of reaction mixes was enzyme 
preparation. This resulted in a final concentration of 0.64% CHAPS, 
well into the inhibition zone depicted in Figure 10. To reduce the 
CHAPS concentration, overnight dialysis in 7 volumes of 25 mM 
Tris-HCl, pH 7.4, at 4° C was performed. 
The recovery of the deiodinase activity by overnight dialysis 
as measured by the T^ radioimmunoassay is shown in Table III. 
Although there is some loss of activity as the enzyme was purified 
from microsomes, deiodinase activity was recoverable in the dialyzed 
enzyme preparations corresponding to deiodinase A. This 5’-deiodianse 
activity was readily stimulated by the addition of NADP and DTT. 
The amount of enzyme available using the 5 ml DEA.F, column was 
insufficient for our protocol. In Figure 11 and 12, the comparison of 
the fractional activities between the large column (5 x small column) 
125 
and small column, measured by I-T^ deiodinase assay, is shown. The 
elution profile of the large column correlated well with the small 
column. This enabled us to increase the volume of enzyme to be 
chromatograhed proportionally by 5 times and the pooling of the 
"breakthrough" and "wash" fractions as deiodinase A, and the 
"elution" fractions (E3-E6) as deiodinase B. 
I •■'i- 
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Table IV demonstrates that the increase of column size and 
pooling of the enzyme fractions preserved the activity in deiodinase 
A as measured by radioimmunoassay. The activity was 
synergistically enhanced by the addition of NADP and DTT. 
The amount of T^ generated by deiodinase B was not significant. 
Various concentrations of T, were then studied with a constant 
4 
concentration of enzyme as shown in Table V. At 0.1 uM T^, T^ 
production was below detectable levels. Both at 0.5 uM and at 1.0 uM 
T^, deiodinase A activity can be demonstrated which is stimulated by 
NADP and DTT. Substrate concentration does not appear to be rate- 
limiting in our assay system. With and without the addition of NADP 
and phospholipids, only minimal amount of T^ was detectable in the 
deiodinase B fraction. 
‘ 
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DISCUSSION 
The presence of deiodinase activity in rat microsoir.es has 
125 
been well documented (11,29,40,41,42,43). Using I-T^ as substrate, 
deiodinase activity was detected using Dowex AG 50-X8 anion exchange 
chromato- graphy by the generation of free ^ I. Purification of 
microsomal activity by CHAPS solubilization, by acidification, and by 
DEAE- Sephadex A25 column chromatography resulted in the separation 
of the activity into two deiodinase activities. The first peak of 
activity (deiodinase A) , which eluted as the "breakthrough" and 
"wash" fractions, was stimulated by the addition of NADP and DTT. The 
second peak of activity (deiodinase B) , eluted with 0.4 M NaCl and 
ovalbumin (1.0 mg/ml), was stimulated by NADP in the presence of 
phospholipids. Using a T^-specific radioimmunoassay, the generation 
of T^ was studied in both deiodinase activities. The addition of NADP 
and DTT markedly stimulated the production of T^ by the deiodinase 
activity A. This finding supported the results of the T. deiodinase 
assay. Much less T^ was detectable by radioimmunoassay in deiodinase 
B incubated with T^ with and without NADP and phospholipids. The 
presence of deiodinase B activity was however shown by the production 
125 125 . 
of free I from I-T, deiodinase assay. 
125 125 
The amount of I released from " I-T^ by either deiodinase 
A or B was significantly greater than the amount of T^ formed; the 
amount of T^ was less than 1% of the total free 
125 
I released. There 
. ' 3. ' 
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are a few possible reasons for this discrepancy. 
HPLC analysis of the products of both deiodinases showed that 
125 
the major product was free ' I with much smaller amounts of 
radioactivity corresponding to T^, rT^, and T?. Using our assay, 
partially purified microsomal deiodinases A and B are capable of 
converting thyroxine to and subsequently to further degradative 
products. Therefore, only a small fraction of degraded accumulates 
as T„. This finding is consistent with the hypothesis that thyroxine 
is converted to TQ and rTQ and subsequently into further degradative 
J J 
products as reported in the literature (37,38,40,41,42,43,47). 
1 25 
The I-T^ used in these studies contains a single 
radioactive iodide in the outer ring of thyroxine. As such, HPLC 
detection of the breakdown products of thyroxine is possible only for 
deiodination of the inner ring, the unlabelled outer ring iodide, and 
ether-link cleavage. If the labelled iodide is cleaved, only free 
125 
I will be detected. Preferential deiodination of the labelled 
iodide may occur due to a kinetic isotope effect. This may also 
125 
contribute to the discrepancy between the free I and T^ detected. 
Finally, the presence of an ether-link cleavage activity has 
been reported by Balsam et al (18). The labelled ether-link cleavage 
product may elute from Dowex chromatography under the same conditions 
that free 
125 
I elutes. This can result in the false detection of the 
125 
the ether-link cleavage product as "free I" and contribute further 
to the discrepancy. 
.ll U'i 
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The observation that significant was converted to T0 as 
detected by T0 radioimmunoassay by deiodinase A but not by deiodinase 
B suggests that either 5'-deiodinase activity is absent in deiodinase 
B or that under our assay condition, T^ produced was rapidly degraded 
into further breakdown products of thyroxine and does not accumulate 
in sufficient quantity for detection by the radioimmunoasssay. 
Inhibition of deiodination and kinetics studies are needed to 
verify the existence of 5’-deiodinase activity in deiodinase B. 
CHAPS solubilization of roicrsosomes and subsequent DEAE- 
Sephadex A25 column chromatography represents a novel purification 
procedure. Deiodinase activities A and B may be unique; the 
activities reported here are stimulated by NADP, much less by NAD, 
and not at all by the reduced forms, NADH and NADPH. 
In a review of the literature, there has been no NADP- 
dependent or enhanced 5’-deiodinase reported. Visser reported NAD, 
but not NADH, NADP, or NADPH, to be stimulatory for the 5’-deiodinase 
in rat liver microsomes (40,41,43). The association of deiodination 
with NADPH-dependent lipid peroxidation in a submicrosoma 1 system has 
also been reported (36). In fasting rats, the decreased T^ to T^ 
conversion was reported to be due to a missing factor in the cytosol, 
correctable by the addition of NADPH (3,23). Visser proposed that the 
lower glucose availability state in fasting leads to depresssed 
hexose monophosphate shunt pathway activity and thus a low NADPH 
Vf? ' ' 
27 
level (43). This relationship between the hexose monophosphate shunt 
pathway and to conversion was subsequently demonstrated by 
Sato (31). The proposed mechanism suggested that NADPH restores 
cytosolic glutathione, an in vivo thiol cofactor for the enzyme. In 
rat liver microsomes of hypothyroid rats, the defect lies in the 
5'-deiodinase. Accordingly, NADPH replacement has been shown to be 
ineffective in correcting the decreased activity (2) 
One possibile explanation for the NADP requirement in 
deiodinase activities A and B may be that the increase in the amount 
of T^ deiodinated in presence of NADP resulted from NADP enhancement 
of deiodinases other than the 5'-deiodinase, thus leading to an 
increased turnover rate of T^ as exemplified by the high rate of 
125 
I-T. deiodination but not of T~ accumulation by deiodinase B 
4 3 
activity. The other possible explanation is that the deiodinase A and 
E activities reported here represent novel activities recovered by 
CHAPS solubilization of microsomes. Further correlation with the 
deiodinase activitites reported in the literature would involve 
testing for PTU-sensitivity in deiodinase activities A and B, and 
comparison of kinetic properties. 
The use of cholate and a mixture of nonionic Brij detergents 
to solubilize rat liver and kidney microsomes resulting in partial 
inactivation of the enzyme has been reported(12,26). The partial 
delipidation involved in solubilization may be a factor in the 
incomplete recovery of activity. The addition of phospholipids 
.... 
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have been reportedto improve deiodinase activity (26). The addition 
of a phospholipids mixture with its composition as described per 
Methods resulted in the increase of deiodinase B activity detected by 
the release of ^^1 from ^^I-T, . Further work on the identification 
4 
of specific phospholipid requirements may improve the yield by 
deiodinase B thus allowing for further characterization of the 
activity. 
The presence of detergents have also been implicated for 
decreased deiodinase activity (12). The use of CHAPS detergent in 
concentration higher than 0.2 % resulted in the complete inactivation 
125 
of the deiodinase activity as measured by release of free I. Thus 
overnight dialysis of the enzyme prep to decrease the concentration 
of CHAPS to 0.1% was undertaken with subsequent recovery of some T^ 
to T^ conversion activity by deiodinase A. The possibility that 
enzyme denaturation and precipitation from overnight dialysis and 
decreased CHAPS concentration caused the decrease in activity cannot 
be excluded and thus needs further evaluation. 
In summary, CHAPS solubilization, acidification, and 
subsequent DEAE-Sephadex A25 column chromatography of rat liver 
microsomes resulted in the separation of two deiodinase activities 
125 125 
as measured by the release of free I from I-T^.Characterization 
of the activities revealed a stimulatory effect of NADP on both 
activities. The addition of DTT with NADP to deiodinase A showed 
-j --•_ > 
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synergistically increased deiodinase activity. Similarly, the 
addition of phospholipids with NADP enhanced the activity of 
deiodinase B. Using a T^-specific radioimmunoassay, conversion of 
to was detected in deiodinase A preparations, enhanced by the 
presence of NADP and DTT. Only minimal amount of was detectable in 
deiodinase B preparations. The amount of detected was less than 1% 
125 125 
of the amount of free I released from I-T.. This is consistent 4 
with the hypothesis that thyroxine is converted to T^ and rT^ and 
subsequently into further degradative products as suggested by 
Watkins' HPLC data (publication in preparation) and in the literature 
(37,38,40,41,42,43,47). The results presented here provide a basis 
for further studies on CHAPS solubilization of microsomes as a mean 
of deiodinase purification to characterize the identity of the 
various deiodinases present in extrathyroidal tissue. 
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PTU-SENSITIVE PATHWAY 
DTT 
FIG. 3 
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FIG. 4. Standard T~ RIA curve using 1:1 500 ul aliquots 
TM 1? F ^ 
of Amerlex I-T^ t0 anti-T^ antibody with 50 ul of 
increasing concentration of unlabelled in 50 mM MES, 
pH6.0, and ovalbumin (1.0 mg/ml), incubated at 37° C 
for 60 min. 
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125 FIG. 5. Deiodinase activity, as measured by CPM of free I 
(with controls subtracted), in the (H) homogenate fraction, 
(M) microsomes, (C) CHAPS-solubi1ized microsomes, and (S) pH 
4.5 supernatant (CHAPS-solubi1ized microsomes treated with 0.1 
vol of NaAcetate, pH 4.5 and neutralized with Iris-base to pH 
7-7.5 as per Methods and Materials) is shown. Standard reaction 
mixes, in a total volume of 0.1 ml, containing 50 mM MF.S, pH 
6.0, ovalbumin (1.0 mg/ml), 25 nM I-T^, and 10 ul of the 
indicated enzyme prep (H,M,C,orS) with rv ^ and without | 1 
3 mM NADP, were incubated at 30° C for 10 min. 
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FIG. 6. DEAE-Sephadex chromatography of the neutralized pH 4.5 
supernatant. Deiodinase activity in the (BT) "breakthrough" and 
(W1,W2,W3) "washes" (3 X 5ml aliquots of 25 mM Tris-HCl, pH 7.5, 
0.8% CHAPS), designated as deiodinase A, and in the (E1,E2, 
E3,E4) "eluates" (4 X 1 ml aliquots of 25 mM Tris-HCl, pH 7.5, 
0.8% CHAPS, 0.4 M NaCl and ovalbumin (1.0 mg/ml)), designated as 
125 
deiodinase B, is demonstrated by I-T^ deiodinase assay. 
Standard reaction mixes and assay conditions as per Methods and 
Materials with (6B) and without (6A) 5mM of DTT, and in the 
presence and absence of 3mM NADP. 
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T&ioAinase A D^p^nvaseb 
FIG. 7. DEAE-Sephadex chromatography of the neutralized pH 4.5 
supernatant. Activity in deiodinase A and deiodinase B is 
125 
demonstrated by I-T^ deiodinase assay. Standard reaction mixes 
and assay conditions as per Methods and Materials with the 
addition of 10 ul of phospholipids with (7B) and without (7A) 3 mM 
NADP. 
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FIG. 8. Deiodinase activity, as measured by picograms of 
produced, in the supernatant of liver homogenate centrifuged at 
2 000 x g (SUP 1), then at 25 000 x g (SUP 2), and finally at 
105 000 x g (SUP 3), and in the microsomes (M), is shown. Standard 
reaction mixes, in total volumes of 0.25 ml, containing 50 mM MES, 
pH 6.0, ovalbumin (1.0 mg/ml), 1 uM , 0.2 ml of the indicated 
enzyme prep, with and without I | 3 mM NADP and 5 mM 
DTT, were incubated at 30° C for 25 min. Reactions were then 
terminated by transferring a 0.2 ml aliquot to a microfuge tube 
containing 0.4 ml ice cold ethanol. RIA was then performed as 
per Methods and Materials. 
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FIG. 9. Microsomes, treated with 0.8% CHAPS, centrifuged at 
105 000 x g, produced a CHAPS - soluble (C-SOL) and a CHAPS — 
insoluble pellet (C-PEL). The pH of a portion of the CHAPS-soluble 
fraction was then lowered by the addition of 0.1 vol NaAcetate, pH 
4.5, kept for 15 min. in ice, and centrifuged at 7 000 x g for 10 
min, separating the prep into a pH 4.5 supernatant and a 
precipitate. The supernatant was neutralized with Tris-base to pH 
7-7.5 (4.5 SUP) and the pellet was resuspended in 5 vols of 25 mM 
Tris-HCl, pH 7.5 (4.5 PEL). The deiodinase activity, measured by 
picograms of T^ produced, is shown. Standard reaction mixes, 
with and without 1 ~l 3 mM NADP, 5 mM DTT, and 10 ul 
phospholipids, and assay conditions are identical to those 
as per Methods and Materials. 
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FIG. 11. DEAE-Sephadex column chromatography comparing the 
elution profile of deiodinase activity in the small column 
(with I 
column 
without 
(5 
and without 
X vols of 
3 mM NADP) versus the large 
small column) (with 
125 
and 
3 mM NADP) by I-T. deiodinase assay in the (BT) 
"breakthrough" and (Wl,W2,W3) "washes". 

FIG. 12. DEAE-Sephadex column chromatography comparing the 
elution profile of deiodinase activity in the small column 
(with [ and without 3 mM NADP) versus the large 
column (with and without 3 mM NADP) by 
125 
I-T, 
deiodinase assay in the (El,E2,E3,E4,E5,E6,E7) eluates. 
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Table I. RIA Specificity : 
Percent cross-reactivity with other 
iodothyronines 
TYPE OF 
IODOTHYRONINE 
PICOGRAMS OF 
IODOTHYRONINE3 
PICOGRAMS OF 
TRIIODOTHYRONINE5 
% CROSS¬ 
REACTIVITY' 
T 2 1840 
o
 
o
 
<r
 2.2 
rT3 2290 4.9 0.2 
T4 
3110 33.0 1.1 
T3 
120 118.6 98.8 
Picograms of indicated iodothyronine (a) detected as picograms 
of T3 (b) by RIA. 
% Cross-reactivity = b/a X 100 
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Table II. RIA of microsomes, pH 4.5 supernatant 
and delodinase A for production. 
NADP/DTTa MICR0S0MESb 
pH 4.5 
SUPERNATANT0 DEIODINASE Ad CONTROL' 
+ 237 114.5 84.4 91.2 
- 86.4 79.1 79.0 87.9 
Units in picograms T^. 
Incubation time = 20 min. 
In the presence (+) and absence (-) of 3 mM NADP and 5 mM 
DTT. 
b,C,d Enzyme preparations, standard reaction mixes and assay 
conditions as per Methods. 
0 
Control = 1 uM in standard reaction mixes without enzyme. 
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Table III. RIA of microsomes, pH 4.5 
dialyzed deiodinase A for 
supernatant 
production 
and 
NADP/DTTa MICR0S0MESb 
pH 4.5 
SUPERNATANT0 
DIALYZED 
DEIODINASE A° CONTROL6 
+ 227 140 112 86.0 
89.0 81.0 85.0 73.0 
Units in picograms T^. 
Incubation time = 20 min. 
In the presence (+) and absence (-) of 3 mM NADP and 5 mM 
DTT. 
b,C,C* Enzyme preparations, standard reaction mixes and assay 
conditions as per Methods. 
e 
Control = 1 uM in standard reaction mixes without enzyme. 
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Table IV. RIA of deiodinase A and B 
NADP/DTT DEIODINASE A CONTROL 
+ 155.0 130.5 
- 128.5 140.5 
NADP/PL" DEIODINASE B CONTROL 
+ 124.0 124.8 
- 120.5 122.0 
Units and symbols similar to previous tables. 
Incubation time =1 hr. 
In the presence (+) and absence (-) of 3 mM NADP and 10 ul 
phospholipids mix as per Methods. 
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Table V. T RIA of deiodinase A and ^ using 
0.1 uM, 0.5 uM and 1.0 uM T as substrate 
0.1 uM T4 0.5 uM T4 
1.0 uM T 
NADP/DTT DEIODINASE 
A CONTROL 
DEIODINASE 
A CONTROL 
DEIODINASE 
A CONTROL 
+ 0-10 0-10 56.2 43.8 128 112 
_ 0-10 0-10 40.0 41.8 133 85.8 
NADP/PLa 
0. 1 
DEIODINASE 
uM T. 
4 
0.5 
DEIODINASE 
uM T. 
4 
1.0 
DEIODINASE 
uM T. 
4 
A CONTROL A CONTROL A CONTROL 
+ 44.3 0-10 50.0 37.8 118 112.9 
- 0-10 0-10 52.0 47.8 116 - 
Units and symbols similar to previous tables. 
Incubation time = 20 min. 
In the presence (+) and absence (-) of 3mM NADP and 10 ul 
phospholipids mix per Methods. 
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